US clinical trial of antiviral for monkeypox begins

US clinical trial of antiviral for monkeypox begins

Sep 13, 2022 | News

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators aim to enroll more than 500 people from clinical research sites nationwide....